Zylö Therapeutics Closes $5.225 Million Series B Financing
03 juin 2022 09h00 HE
|
Zylö Therapeutics
GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series...
PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor
16 oct. 2018 12h05 HE
|
PanTher Therapeutics
CAMBRIDGE, Mass., Oct. 16, 2018 (GLOBE NEWSWIRE) -- PanTher Therapeutics, the biotech company developing drug-delivery platforms for unresectable, locally advanced solid tumors, today announced an...